High-throughput fermentation and bio-active discovery platform for health-optimized fermented foods

Overview

This solution offers a high-throughput screening platform for food fermentation that links microbial activity to measurable health benefits. The platform builds on the ALL-INFORMED approach for flavor optimization and extends it with state-of-the-art plant metabolomics to systematically identify and quantify bio-active compounds produced during fermentation. The goal is to determine which ferments and postbiotics deliver the strongest health-promoting effects, reducing the risk of failure in downstream clinical trials and accelerating the development of functional fermented food products.

The platform addresses a clear market need: populations consuming a Westernized diet show a continuous decline in gut microbiome diversity, and fermented foods are increasingly recognized as a practical route to reverse this trend. By combining controlled fermentation with analytical profiling, the platform enables partners to rationally select microbial strains and substrates that produce targeted health-relevant compounds rather than relying on empirical trial-and-error.

Technical specifications

Platform capabilities:

• High-throughput fermentation screening using the ALL-INFORMED methodology for rapid evaluation of microbial strains and substrate combinations
• Plant metabolomics integration to identify and quantify microbially derived bio-actives generated during fermentation
• Mapping of microbial activity to known health-promoting pathways, including cholesterol-lowering, antioxidant, antidiabetic, and antihyperlipidemic effects
• In vitro assay selection driven by predicted health-benefit profiles to substantiate predicted bioactivity
• Reference integration with biological databases and scientific literature to prioritize the most promising ferment candidates

Fermentation outputs characterized include:

• Conversion of carbohydrates to bioactive sugars and oligosaccharides
• Formation of bioactive peptides from proteins
• Production of fatty acids and other lipid-derived bio-actives

Technology readiness level

The fermentation platform is currently operational and being used for flavor optimization work. The extension to include plant metabolomics and health-focused bio-active profiling represents an active development effort. Validation to date is supported by extensive published evidence linking fermented foods and postbiotics to measurable health benefits, including cholesterol-lowering, antioxidant, antidiabetic, and antihyperlipidemic effects. The next stage involves detailed analysis linking specific microorganisms to health outcomes, followed by high-throughput fermentation of plant-based substrates and targeted in vitro assays to confirm predicted health benefits prior to clinical evaluation.